Chiral separation of rac-Ornidazole and detection of the impurity of (R)-Ornidazole in (S)-Ornidazole injection and raw material

(S)‐Ornidazole is a subject of research as an antifertility agent in male animals at present. However, there seems to be no relative report on chiral separation for rac‐Ornidazole, which has been used as an effective medicine for more than 30 years. In this article, the chiral separation of rac‐Orni...

Full description

Saved in:
Bibliographic Details
Published inChirality (New York, N.Y.) Vol. 18; no. 8; pp. 587 - 591
Main Authors Huang, Jianquan, Cao, Guoying, Hu, Xin, Sun, Chunhua, Zhang, Junren
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 2006
Subjects
Online AccessGet full text
ISSN0899-0042
1520-636X
DOI10.1002/chir.20292

Cover

Abstract (S)‐Ornidazole is a subject of research as an antifertility agent in male animals at present. However, there seems to be no relative report on chiral separation for rac‐Ornidazole, which has been used as an effective medicine for more than 30 years. In this article, the chiral separation of rac‐Ornidazole on a Chiralcel OB‐H column based on normal‐phase high‐performance liquid chromatography (NP‐HPLC) is investigated and the methodology for detection of impurity of (R)‐Ornidazole in (S)‐Ornidazole injection and raw material is established. The novel mobile phase is utilized by mixing n‐hexane, methanol and isopropyl alcohol (95:4:1, v/v/v) instead of the typical mobile phase of n‐hexane and isopropyl alcohol, although the methanol, which offers a good resolution factor for the enantiomeric separation in this system, is not recommended on the Chiralcel OB‐H column according to the instruction supplied by Daicel Chemical Ind., LTD (Japan). Chirality, 2006. © 2006 Wiley‐Liss, Inc.
AbstractList ( S )‐Ornidazole is a subject of research as an antifertility agent in male animals at present. However, there seems to be no relative report on chiral separation for rac ‐Ornidazole, which has been used as an effective medicine for more than 30 years. In this article, the chiral separation of rac ‐Ornidazole on a Chiralcel OB‐H column based on normal‐phase high‐performance liquid chromatography (NP‐HPLC) is investigated and the methodology for detection of impurity of ( R )‐Ornidazole in ( S )‐Ornidazole injection and raw material is established. The novel mobile phase is utilized by mixing n ‐hexane, methanol and isopropyl alcohol (95:4:1, v/v/v) instead of the typical mobile phase of n ‐hexane and isopropyl alcohol, although the methanol, which offers a good resolution factor for the enantiomeric separation in this system, is not recommended on the Chiralcel OB‐H column according to the instruction supplied by Daicel Chemical Ind., LTD (Japan). Chirality, 2006. © 2006 Wiley‐Liss, Inc.
(S)-Ornidazole is a subject of research as an antifertility agent in male animals at present. However, there seems to be no relative report on chiral separation for rac-Ornidazole, which has been used as an effective medicine for more than 30 years. In this article, the chiral separation of rac-Ornidazole on a Chiralcel OB-H column based on normal-phase high-performance liquid chromatography (NP-HPLC) is investigated and the methodology for detection of impurity of (R)-Ornidazole in (S)-Ornidazole injection and raw material is established. The novel mobile phase is utilized by mixing n-hexane, methanol and isopropyl alcohol (95:4:1, v/v/v) instead of the typical mobile phase of n-hexane and isopropyl alcohol, although the methanol, which offers a good resolution factor for the enantiomeric separation in this system, is not recommended on the Chiralcel OB-H column according to the instruction supplied by Daicel Chemical Ind., LTD (Japan).
(S)-Ornidazole is a subject of research as an antifertility agent in male animals at present. However, there seems to be no relative report on chiral separation for rac-Ornidazole, which has been used as an effective medicine for more than 30 years. In this article, the chiral separation of rac-Ornidazole on a Chiralcel OB-H column based on normal-phase high-performance liquid chromatography (NP-HPLC) is investigated and the methodology for detection of impurity of (R)-Ornidazole in (S)-Ornidazole injection and raw material is established. The novel mobile phase is utilized by mixing n-hexane, methanol and isopropyl alcohol (95:4:1, v/v/v) instead of the typical mobile phase of n-hexane and isopropyl alcohol, although the methanol, which offers a good resolution factor for the enantiomeric separation in this system, is not recommended on the Chiralcel OB-H column according to the instruction supplied by Daicel Chemical Ind., LTD (Japan).(S)-Ornidazole is a subject of research as an antifertility agent in male animals at present. However, there seems to be no relative report on chiral separation for rac-Ornidazole, which has been used as an effective medicine for more than 30 years. In this article, the chiral separation of rac-Ornidazole on a Chiralcel OB-H column based on normal-phase high-performance liquid chromatography (NP-HPLC) is investigated and the methodology for detection of impurity of (R)-Ornidazole in (S)-Ornidazole injection and raw material is established. The novel mobile phase is utilized by mixing n-hexane, methanol and isopropyl alcohol (95:4:1, v/v/v) instead of the typical mobile phase of n-hexane and isopropyl alcohol, although the methanol, which offers a good resolution factor for the enantiomeric separation in this system, is not recommended on the Chiralcel OB-H column according to the instruction supplied by Daicel Chemical Ind., LTD (Japan).
(S)‐Ornidazole is a subject of research as an antifertility agent in male animals at present. However, there seems to be no relative report on chiral separation for rac‐Ornidazole, which has been used as an effective medicine for more than 30 years. In this article, the chiral separation of rac‐Ornidazole on a Chiralcel OB‐H column based on normal‐phase high‐performance liquid chromatography (NP‐HPLC) is investigated and the methodology for detection of impurity of (R)‐Ornidazole in (S)‐Ornidazole injection and raw material is established. The novel mobile phase is utilized by mixing n‐hexane, methanol and isopropyl alcohol (95:4:1, v/v/v) instead of the typical mobile phase of n‐hexane and isopropyl alcohol, although the methanol, which offers a good resolution factor for the enantiomeric separation in this system, is not recommended on the Chiralcel OB‐H column according to the instruction supplied by Daicel Chemical Ind., LTD (Japan). Chirality, 2006. © 2006 Wiley‐Liss, Inc.
Author Zhang, Junren
Cao, Guoying
Huang, Jianquan
Sun, Chunhua
Hu, Xin
Author_xml – sequence: 1
  givenname: Jianquan
  surname: Huang
  fullname: Huang, Jianquan
  email: jianquanhuang@mail.sdu.edu.cn
  organization: Institute of Pharmaceutical Analysis, College of Pharmacy, Shandong University, P.R. China
– sequence: 2
  givenname: Guoying
  surname: Cao
  fullname: Cao, Guoying
  organization: Department of pharmacy, Beijing Hospital, Ministry of Health, Beijing, P.R. China
– sequence: 3
  givenname: Xin
  surname: Hu
  fullname: Hu, Xin
  organization: Department of pharmacy, Beijing Hospital, Ministry of Health, Beijing, P.R. China
– sequence: 4
  givenname: Chunhua
  surname: Sun
  fullname: Sun, Chunhua
  organization: Department of pharmacy, Beijing Hospital, Ministry of Health, Beijing, P.R. China
– sequence: 5
  givenname: Junren
  surname: Zhang
  fullname: Zhang, Junren
  organization: Institute of Pharmaceutical Analysis, College of Pharmacy, Shandong University, P.R. China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16642497$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtP4zAURi3ECMpjww9AWSEGKXBtxw5ZoooBJB5ShwF21m1yIwx5FNsVlBU_fVLaMgihkReWr8_5FvdbY8tN2xBjWxz2OYA4yO-t2xcgMrHEelwJiLXUd8usB4dZFgMkYpWtef8AAJmWyQpb5VonIsnSHnvrdzJWkacROgy2baK2jBzm8ZVrbIGvbUURNkVUUKB88R_uKbL1aOxsmEzfu4Ofn3nbRLu_v0we5vY0y-FzVGMgZ7HaYD9KrDxtzu919ufX8XX_ND6_OjnrH53HudRKxEQqK4VQPMtESQqh7I6WMOQ6L5QeFpKXqVQ8KZCDEolC5EKDKoSUXA5BrrOdWe7ItU9j8sHU1udUVdhQO_ZGH6ZdtlQduD0Hx8OaCjNytkY3MYuddcDeDMhd672j8h8CZlqImRZi3gvpYPgC5za87zk4tNX3Cp8pz7aiyX_CTf_0bLBw4pljfaCXDwfdo9GpTJW5vTwxfHB9cadvLs2N_Au3q6xn
CitedBy_id crossref_primary_10_1002_jssc_200900855
crossref_primary_10_1365_s10337_008_0625_3
crossref_primary_10_1021_ac070708x
crossref_primary_10_1016_j_talanta_2012_12_007
crossref_primary_10_5012_bkcs_2007_28_6_1035
crossref_primary_10_12659_MSM_882514
crossref_primary_10_1016_j_jchromb_2014_05_058
crossref_primary_10_1021_acs_inorgchem_1c03695
Cites_doi 10.1002/(SICI)1520-636X(1997)9:8<722::AID-CHIR2>3.0.CO;2-7
10.3109/00498257909042323
10.1097/00013542-200101000-00001
10.1016/S0021-9673(00)00532-X
10.1080/004982597240299
10.1002/1522-2683(20000601)21:10<1940::AID-ELPS1940>3.0.CO;2-#
10.1530/jrf.0.1000551
10.1007/BF01990326
10.1111/j.1365-2605.1984.tb00762.x
10.1038/224083a0
10.1071/BI9820595
ContentType Journal Article
Copyright Copyright © 2006 Wiley‐Liss, Inc.
Copyright_xml – notice: Copyright © 2006 Wiley‐Liss, Inc.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1002/chir.20292
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1520-636X
EndPage 591
ExternalDocumentID 16642497
10_1002_chir_20292
CHIR20292
ark_67375_WNG_1RTMX6VN_V
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
29B
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIJN
ABOCM
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AI.
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BSCLL
BTSUX
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M21
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2W
P2X
P4D
PALCI
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RWK
RX1
RYL
SAMSI
SUPJJ
TUS
UB1
UPT
V2E
V8K
VH1
W8V
W99
WBFHL
WBKPD
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WXSBR
WYISQ
XG1
XV2
YCJ
ZZTAW
~02
~IA
~WT
AAHQN
AAMMB
AAMNL
AANHP
AAYCA
ACRPL
ACUHS
ACYXJ
ADNMO
AEFGJ
AEYWJ
AFWVQ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
ALVPJ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3652-ee59f2251992fe5a0f0f0630b16cd56bd31f73514da105245aa12605d23313b03
IEDL.DBID DR2
ISSN 0899-0042
IngestDate Thu Sep 04 16:31:44 EDT 2025
Wed Feb 19 01:53:31 EST 2025
Tue Jul 01 02:50:41 EDT 2025
Thu Apr 24 22:51:24 EDT 2025
Wed Aug 20 07:25:48 EDT 2025
Wed Oct 30 09:48:27 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3652-ee59f2251992fe5a0f0f0630b16cd56bd31f73514da105245aa12605d23313b03
Notes istex:2CF4C081152908E9AC4BD40F5EB6DEAAC52144C5
ArticleID:CHIR20292
ark:/67375/WNG-1RTMX6VN-V
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 16642497
PQID 68719935
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_68719935
pubmed_primary_16642497
crossref_primary_10_1002_chir_20292
crossref_citationtrail_10_1002_chir_20292
wiley_primary_10_1002_chir_20292_CHIR20292
istex_primary_ark_67375_WNG_1RTMX6VN_V
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006
PublicationDateYYYYMMDD 2006-01-01
PublicationDate_xml – year: 2006
  text: 2006
PublicationDecade 2000
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: United States
PublicationTitle Chirality (New York, N.Y.)
PublicationTitleAlternate Chirality
PublicationYear 2006
Publisher Wiley Subscription Services, Inc., A Wiley Company
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
References Paias FO, Lanchote VL, Takayanagui OM, Bonato PS. Enantioselective analysis of albendazole sulfoxide in plasma using the chiral stationary phase. Chirality 1997; 9: 722-726.
Schwartz DE, Jordan JC, Vetter W, Oesterhelt G. Metabolic studies of Ornidazole in the rat, in the dog, and in man. Xenobiotica 1979; 9: 571-581.
Stevenson D, Jones AR. Inhibition of fructolysis in boar spermatozoa by the male antifertility agent (S)-alpha-chlorohydrin. Aust J boil Sci 1982; 35: 595-605.
Jenkins SG. Infections due to anaerobic bacteria and the role of antimicrobial susceptibility testing of anaerobes. Rev Med Microbiol 2001; 12: 1-12.
Oberlander G, Yeung CH, Cooper TG. Induction of reversible infertility in male rats by oral Ornidazole and its effects on sperm motility and epididymal secretions. J Reprod Fertil 1994; 100: 551-559.
Blomberg LG, Wan H. Determination of enantiomeric excess by capillary electrophoresis. Electrophoresis 2000; 21: 1940-1952.
Skold M, Gnarpe H, Hillstrom L. Ornidazole: a new antiprotozoal compound for treatment of Trichomonas vaginalis infection. Br J Vener Dis 1977; 53: 44-48.
Stevenson D, Jones AR. The action of (R)- and (S)-alpha-chlorohydrin and their metabolites on the metabolism of boar sperm. Int J Androl 1984; 7: 79-86.
Jones AR, Cooper TG. Metabolism of 36Cl-Ornidazole after oral application to the male rat in relation to its antifertility activity. Xenobiotica 1997; 27: 711-721.
Jones AR, Stevenson D. Formation of the active antifertility metabolite of (S)-alpha-chlorohydrin in boar sperm. Experientia 1983; 39: 784-785.
Jones AR, Davies P, Edwards K, Jackson H. Antifertility effects and metabolism of alpha and epi-Chlorhydrins in the rat. Nature 1969; 224: 83.
Maier NM, Franco P, Lindner W. Separation of enantiomers: needs, challenges, perspectives. J Chromatogr A 2001; 906: 3-33.
1982; 35
1977; 53
1994; 100
1997; 27
2001; 906
1983; 39
2001; 12
1969; 224
2000; 21
1997; 9
1979; 9
1984; 7
e_1_2_1_6_2
e_1_2_1_7_2
e_1_2_1_4_2
e_1_2_1_5_2
e_1_2_1_11_2
e_1_2_1_3_2
e_1_2_1_12_2
e_1_2_1_10_2
e_1_2_1_13_2
Stevenson D (e_1_2_1_8_2) 1982; 35
Skold M (e_1_2_1_2_2) 1977; 53
e_1_2_1_9_2
References_xml – reference: Jones AR, Cooper TG. Metabolism of 36Cl-Ornidazole after oral application to the male rat in relation to its antifertility activity. Xenobiotica 1997; 27: 711-721.
– reference: Stevenson D, Jones AR. Inhibition of fructolysis in boar spermatozoa by the male antifertility agent (S)-alpha-chlorohydrin. Aust J boil Sci 1982; 35: 595-605.
– reference: Jones AR, Davies P, Edwards K, Jackson H. Antifertility effects and metabolism of alpha and epi-Chlorhydrins in the rat. Nature 1969; 224: 83.
– reference: Skold M, Gnarpe H, Hillstrom L. Ornidazole: a new antiprotozoal compound for treatment of Trichomonas vaginalis infection. Br J Vener Dis 1977; 53: 44-48.
– reference: Jenkins SG. Infections due to anaerobic bacteria and the role of antimicrobial susceptibility testing of anaerobes. Rev Med Microbiol 2001; 12: 1-12.
– reference: Stevenson D, Jones AR. The action of (R)- and (S)-alpha-chlorohydrin and their metabolites on the metabolism of boar sperm. Int J Androl 1984; 7: 79-86.
– reference: Maier NM, Franco P, Lindner W. Separation of enantiomers: needs, challenges, perspectives. J Chromatogr A 2001; 906: 3-33.
– reference: Paias FO, Lanchote VL, Takayanagui OM, Bonato PS. Enantioselective analysis of albendazole sulfoxide in plasma using the chiral stationary phase. Chirality 1997; 9: 722-726.
– reference: Jones AR, Stevenson D. Formation of the active antifertility metabolite of (S)-alpha-chlorohydrin in boar sperm. Experientia 1983; 39: 784-785.
– reference: Oberlander G, Yeung CH, Cooper TG. Induction of reversible infertility in male rats by oral Ornidazole and its effects on sperm motility and epididymal secretions. J Reprod Fertil 1994; 100: 551-559.
– reference: Blomberg LG, Wan H. Determination of enantiomeric excess by capillary electrophoresis. Electrophoresis 2000; 21: 1940-1952.
– reference: Schwartz DE, Jordan JC, Vetter W, Oesterhelt G. Metabolic studies of Ornidazole in the rat, in the dog, and in man. Xenobiotica 1979; 9: 571-581.
– volume: 39
  start-page: 784
  year: 1983
  end-page: 785
  article-title: Formation of the active antifertility metabolite of ( )‐alpha‐chlorohydrin in boar sperm
  publication-title: Experientia
– volume: 21
  start-page: 1940
  year: 2000
  end-page: 1952
  article-title: Determination of enantiomeric excess by capillary electrophoresis
  publication-title: Electrophoresis
– volume: 35
  start-page: 595
  year: 1982
  end-page: 605
  article-title: Inhibition of fructolysis in boar spermatozoa by the male antifertility agent ( )‐alpha‐chlorohydrin
  publication-title: Aust J boil Sci
– volume: 9
  start-page: 722
  year: 1997
  end-page: 726
  article-title: Enantioselective analysis of albendazole sulfoxide in plasma using the chiral stationary phase
  publication-title: Chirality
– volume: 906
  start-page: 3
  year: 2001
  end-page: 33
  article-title: Separation of enantiomers: needs, challenges, perspectives
  publication-title: J Chromatogr A
– volume: 100
  start-page: 551
  year: 1994
  end-page: 559
  article-title: Induction of reversible infertility in male rats by oral Ornidazole and its effects on sperm motility and epididymal secretions
  publication-title: J Reprod Fertil
– volume: 9
  start-page: 571
  year: 1979
  end-page: 581
  article-title: Metabolic studies of Ornidazole in the rat, in the dog, and in man
  publication-title: Xenobiotica
– volume: 27
  start-page: 711
  year: 1997
  end-page: 721
  article-title: Metabolism of 36Cl‐Ornidazole after oral application to the male rat in relation to its antifertility activity
  publication-title: Xenobiotica
– volume: 7
  start-page: 79
  year: 1984
  end-page: 86
  article-title: The action of ( )‐ and ( )‐alpha‐chlorohydrin and their metabolites on the metabolism of boar sperm
  publication-title: Int J Androl
– volume: 224
  start-page: 83
  year: 1969
  article-title: Antifertility effects and metabolism of alpha and epi‐Chlorhydrins in the rat
  publication-title: Nature
– volume: 53
  start-page: 44
  year: 1977
  end-page: 48
  article-title: Ornidazole: a new antiprotozoal compound for treatment of infection
  publication-title: Br J Vener Dis
– volume: 12
  start-page: 1
  year: 2001
  end-page: 12
  article-title: Infections due to anaerobic bacteria and the role of antimicrobial susceptibility testing of anaerobes
  publication-title: Rev Med Microbiol
– ident: e_1_2_1_13_2
  doi: 10.1002/(SICI)1520-636X(1997)9:8<722::AID-CHIR2>3.0.CO;2-7
– ident: e_1_2_1_5_2
  doi: 10.3109/00498257909042323
– ident: e_1_2_1_3_2
  doi: 10.1097/00013542-200101000-00001
– ident: e_1_2_1_12_2
  doi: 10.1016/S0021-9673(00)00532-X
– ident: e_1_2_1_10_2
  doi: 10.1080/004982597240299
– ident: e_1_2_1_11_2
  doi: 10.1002/1522-2683(20000601)21:10<1940::AID-ELPS1940>3.0.CO;2-#
– ident: e_1_2_1_4_2
  doi: 10.1530/jrf.0.1000551
– volume: 53
  start-page: 44
  year: 1977
  ident: e_1_2_1_2_2
  article-title: Ornidazole: a new antiprotozoal compound for treatment of Trichomonas vaginalis infection
  publication-title: Br J Vener Dis
– ident: e_1_2_1_6_2
  doi: 10.1007/BF01990326
– ident: e_1_2_1_7_2
  doi: 10.1111/j.1365-2605.1984.tb00762.x
– ident: e_1_2_1_9_2
  doi: 10.1038/224083a0
– volume: 35
  start-page: 595
  year: 1982
  ident: e_1_2_1_8_2
  article-title: Inhibition of fructolysis in boar spermatozoa by the male antifertility agent (S)‐alpha‐chlorohydrin
  publication-title: Aust J boil Sci
  doi: 10.1071/BI9820595
SSID ssj0009634
Score 1.768885
Snippet (S)‐Ornidazole is a subject of research as an antifertility agent in male animals at present. However, there seems to be no relative report on chiral...
( S )‐Ornidazole is a subject of research as an antifertility agent in male animals at present. However, there seems to be no relative report on chiral...
(S)-Ornidazole is a subject of research as an antifertility agent in male animals at present. However, there seems to be no relative report on chiral...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 587
SubjectTerms (R)-Ornidazole
(S)-Ornidazole
2-Propanol - chemistry
Animals
Calibration
chiral separation
Chromatography, High Pressure Liquid - instrumentation
Chromatography, High Pressure Liquid - methods
Contraceptive Agents, Male - analysis
Contraceptive Agents, Male - chemistry
Contraceptive Agents, Male - isolation & purification
Contraceptive Agents, Male - standards
Drug Contamination
Drug Stability
Hexanes - chemistry
impurity detection
Male
Molecular Structure
normal-phase high-performance liquid chromatography
Ornidazole - analysis
Ornidazole - chemistry
Ornidazole - isolation & purification
Ornidazole - standards
Reproducibility of Results
Solutions - chemistry
Stereoisomerism
Title Chiral separation of rac-Ornidazole and detection of the impurity of (R)-Ornidazole in (S)-Ornidazole injection and raw material
URI https://api.istex.fr/ark:/67375/WNG-1RTMX6VN-V/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fchir.20292
https://www.ncbi.nlm.nih.gov/pubmed/16642497
https://www.proquest.com/docview/68719935
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqcoALj5bHtjwsgaoWKW1ix04tcakWyoLURVraspfKsmNHLG2dKrsroCdOnPmN_BLGzmajhQoJlEsSjR3HHme-cWY-I_QMjLRmMbER2B8TpZzrSCiro1wYk6WG72rhE4UP-rx3lL4dsuESetHkwtT8EPMFNz8zwvfaT3ClxzstaWj-ceT5PInwH-CEck-c_3LQckeBZgXuqF2fZg-qOecmJTtt0QVrdM137JeroOYicg2mZ_8WOmkaXUecnG5PJ3o7v_yNz_F_3-o2ujnDpHivVqI7aMm6FbS658AfP_-KN3CIEg3L7yvoerfZIW4Vfe9CNVBwbGsC8dLhssCVyn9--_GuciOjLsszi5Uz2NhJiPkKEoA58ej8Iuyb5683B1uLJUYOb77_496nWQ2-vkp9xoC1w_S5i472Xx12e9FsX4cop5yRyFomCuJTZgUpLFNxAQensU54bhjXhiZF5jMMjAL0R1KmVOLdLkMoTaiO6T207EpnHyAMdldYkVLw8WMws7nggiYmKygH7GKzrIO2mvGV-Yz03O-9cSZrumYifYfL0OEd9HQue1FTfVwptRHUZC6iqlMfHJcx-aH_WiaDw4MhP-7L4w560uiRhHHx_2GUs-V0LDk4qQALWQfdr9WrfRwHdzAV0OznQUn-0g7Z7b0ZhLO1fxFeRzfaRaSHaHlSTe0jgFUT_ThMn1-v_h71
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZQeygXHi3QLY9aAlUtUtrETpz6WC2ULXQXadmWvVlO7IjtI6myuwJ64sSZ38gvYcbJbrRQIYFySaKxkzjjzDfOzDeEvAAjnUQ-sx7YH-OFQiSe1DbxUmlMHBqxn0hMFO72ROckfDuMhnVsDubCVPwQ8wU3nBnue40THBek9xrW0PTTCAk9mYQv8HIISAN9r1f9hj0KdMuxR-1joj0o55ydlO01bRfs0TIO7ZebwOYidnXG5_BuVWF17DgLMebkfHc6SXbT698YHf_7ue6ROzUspQeVHt0nt2y-StYOcnDJL7_SLeoCRd0K_CpZac-KxK2R723oBhqObcUhXuS0yGip05_ffrwv85HR18WFpTo31NiJC_tyEgA76ejyypXOw-Pt_s5ii1FOtz_8ce6s7gH7K_VnCnDbzaAH5OTw9aDd8erSDl7KRcQ8ayOZMcyalSyzkfYz2AT3k0CkJhKJ4UEWY5KB0QAAWRhpHaDnZRjnAU98_pAs5UVu1wkF0yutDDm4-T5Y2lQKyQMTZ1wAfLFx3CI7sxes0pr3HMtvXKiKsZkpHHDlBrxFns9lryq2jxultpyezEV0eY7xcXGkPvbeqKA_6A7FaU-dtsjmTJEUvBf8FaNzW0zHSoCfCsgwapFHlX41lxPgEYYSbvul05K_3Idqd476bm_jX4Q3yUpn0D1Wx0e9d4_J7WZN6QlZmpRT-xRQ1iR55ubSL49HIxQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VrQRceLQ8llctgaoWKW0Sx04tcakWlm2hC1rashdkObEjlrbJKt0V0BMnzvxGfgljZ7PRQoVUlEsSjR3HHme-cWY-AzxFI50wPzQe2h_tRZwnnlAm8VKhdRxpvp0Imyi83-Pdw2hvwAYL8LzOhan4IWYLbnZmuO-1neAjnW01pKHpp6Hl8wwFfoCXIo5QwkKifkMeharlyKO2bZ496uaMnDTcasrOmaMl27NfL8Ka89DV2Z7ODfhYt7oKOTnenIyTzfT8D0LH_32tm3B9CkrJTqVFt2DB5MuwspOjQ376jawRFybq1t-X4Wq73iJuBX60sRoseGYqBvEiJ0VGSpX--v7zbZkPtTovTgxRuSbajF3Ql5NA0EmGpyO3cZ69Xu9vzJcY5mT9_V_3Pk9rsPWV6gtBsO3mz2047Lw8aHe96cYOXko5Cz1jmMhCmzMrwsww5Wd4cOonAU8144mmQRbbFAOtEP6FEVMqsH6XDikNaOLTO7CYF7m5BwQNrzAioujk-2hnU8EFDXScUY7gxcRxCzbq8ZXplPXcbr5xIiu-5lDaDpeuw1vwZCY7qrg-LpRac2oyE1HlsY2Oi5n80Hslg_7B_oAf9eRRC1ZrPZI4LvZHjMpNMTmTHL1UxIWsBXcr9Woex9EfjAQ2-5lTkn-0Q7a7u313dv8ywqtw5d2Ljnyz23v9AK41C0oPYXFcTswjhFjj5LGbSb8BEeIhww
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chiral+separation+of+rac+%E2%80%90Ornidazole+and+detection+of+the+impurity+of+%28+R+%29%E2%80%90Ornidazole+in+%28+S+%29%E2%80%90Ornidazole+injection+and+raw+material&rft.jtitle=Chirality+%28New+York%2C+N.Y.%29&rft.au=Huang%2C+Jianquan&rft.au=Cao%2C+Guoying&rft.au=Hu%2C+Xin&rft.au=Sun%2C+Chunhua&rft.date=2006&rft.issn=0899-0042&rft.eissn=1520-636X&rft.volume=18&rft.issue=8&rft.spage=587&rft.epage=591&rft_id=info:doi/10.1002%2Fchir.20292&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_chir_20292
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0899-0042&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0899-0042&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0899-0042&client=summon